Companies · Medical Devices

Momentis Surgical Ltd.

Or Yehuda · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Momentis Surgical Ltd. — recommendation, valuation, rhythm, risks.
$95.7M
Total raised · real
4
Rounds
2.4×
Latest step-up
Top 4%
Sector rank · raised
Series C
Latest stage · inferred · Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Momentis Surgical Ltd. has raised $96M over 4 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Active
  • Last raise 12 mo ago; this sector typically re-raises about every 16 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Momentis Surgical Ltd. is one of 233 Medical Devices companies tracked from Or Yehuda. By capital raised it ranks among the largest (ahead of 97% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
50
Investors (latest)
2025-07-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries A · 2020-11-23 Raised $11M (real) Modeled valuation $233M (est)$11M$233MSeries A2020Series C · 2020-11-23 Raised $76M (real) Modeled valuation $1.9B (est)$76M$1.9BSeries C2020Series C · 2022-08-30 Raised $4.4M (real) Modeled valuation $63M (est)$4.4M$63MSeries C2022Series C · 2023-11-16 Raised $628K (real) Modeled valuation $6.4M (est)$628K$6.4MSeries C2023Series A · 2023-11-16 Raised $5.9M (real) Modeled valuation $38M (est)$5.9M$38MSeries A2023Series C · 2025-07-15 Raised $14M (real) Modeled valuation $89M (est)$14M$89MSeries C2025+$76M+$4.4M+$628K+$5.9M+$14MCumulative $113M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$11.3M · 2020
Series C$76.4M · 2020no Series B on file
Series C extension$4.4M · 2022
Series C extension$628K · 2023
Bridge · Series C-stage$5.9M · 2023smaller follow-on
Series C extension$14.3M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$88.8M
Base estimate est.
$49.8M
Conservative case
$117.0M
Upside case
$95.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Series A · modeled $233.3M · 2020-11-232020Series C · modeled $1.9B · 2020-11-23Series C · modeled $63.4M · 2022-08-30Series C · modeled $6.4M · 2023-11-16Series A · modeled $37.6M · 2023-11-16Series C · modeled $88.8M · 2025-07-152025
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
70%
Survival probability
52% low · 81% high
1.34×/yr
Annual markup
1.54×/yr upside case
1.0 yr
Elapsed time used
1.0 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$20.6M/yr
Capital velocity
5.6 yr
On record since
2020
First round
6
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 37× above median
This company$95.7M
Sector median$2.6M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.3× of median
This company$14.3M
Sector median$46.9M
Modeled value — vs sector median (estimate, all stages) 5.8× above median
This company$88.8M
Sector median$15.4M

Raised more than 97% of sector peers (real $). Modeled value above 87% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

Not enough valued peers in this cohort to chart positioning.

CompanyStageRaised · realValue · estvs peer med.
Quantum Surgical IncSeries C$75.0M$456.9M1.67×
Momentis Surgical Ltd. this companySeries C$95.7M$88.8M0.33×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$11.3M2020-11-23$51.4M$233.3M90%
Series C$76.4M2020-11-23$509.1M$1.9B90%
Series C$4.4M2022-08-30$29.2M$63.4M90%
Series C$628K2023-11-16$4.2M$6.4M90%
Series A$5.9M2023-11-16$26.9M$37.6M90%
Series C$14.3M2025-07-15$95.4M$88.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$11.3M2020-11-23
    • First recorded raise — entered as Series A.
    • 7 investors on this round.
  2. Series C$76.4M2020-11-23
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 6.7× larger than the prior — scaling up.
    • 54 investors on this round.
  3. Series C$4.4M2022-08-30
    • Raised 21 mo later, in step with the ~16 mo sector norm.
    • Round 17.4× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  4. Series C$628K2023-11-16
    • Raised 15 mo later, in step with the ~16 mo sector norm.
    • Round 7.0× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  5. Series A$5.9M2023-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 9.4× larger than the prior — scaling up.
    • 30 investors on this round.
  6. Series C$14.3M2025-07-15
    • Raised 20 mo later, in step with the ~16 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 50 investors on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~11mo cadence
$34.6M
Modeled next size est.range $22.5M$55.3M
2.4×
Last step-up
$20.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Maurice Ferre4 other2020-11
Eyal Lifschitz2 other2020-11
Israel Frieder2 other2020-11
Dvir Cohen1 other2020-11
Michael Stansky1 other2023-11
Morry Blumenfeld1 other2023-11
Frederic Moll, M.D.2023-11
Hagai Berkovich2020-11
Irit Yaniv2020-11
Lior Shahory2020-11
Nataly Fellous2023-11
Noam Atar2020-11
Sandra Morgan2023-11
Steven Nunes2020-11
Registry & provenance

Momentis Surgical Ltd. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1834887
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
ACTIV Surgical, Inc.Medical DevicesSeries C$86.6M$239.9Msame sector · same stage
Interpace Diagnostics Group, Inc.Medical DevicesSeries C$113.1M$364.8Msame sector · same stage
Quantum Surgical IncMedical DevicesSeries C$75.0M$456.9Msame sector · same stage
Digital Diagnostics Inc.Medical DevicesSeries C$139.0M$1.2Bsame sector · same stage
Redcliffe Lifetech IncMedical DevicesSeries C$46.9M$818.3Msame sector · same stage
MIVI Neuroscience, Inc.Other Health CareSeries C$67.4M$4.3Mnetwork1 shared operator · same stage
Bardy Diagnostics, Inc.Medical DevicesSeries B$89.8M$11.9Msame sector
Zenflow, Inc.Medical DevicesSeries B$75.3M$116.6Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
OnPoint Surgical, Inc.Medical DevicesPre-Seed$7.4M84%
Nami Surgical LtdMedical DevicesPre-Seed$595K84%
ACTIV Surgical, Inc.Medical DevicesSeries C$239.9M84%
Onkos Surgical, Inc.Medical DevicesSeries B$595.1M83%
KMD Surgical Solutions, Inc.Medical DevicesPre-Seed$3.8M82%
Pace Surgical, Inc.Medical DevicesSeed$3.4M82%
IC Surgical, Inc.Medical DevicesPre-Seed$5.5M82%
Surgical Care Partners of Melbourne, LLCMedical DevicesPre-Seed$1.9M82%
Frequently asked
How much funding has Momentis Surgical Ltd. raised?
Momentis Surgical Ltd. has raised approximately $95.7M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Momentis Surgical Ltd.'s estimated valuation?
Provath's modeled valuation for Momentis Surgical Ltd. is approximately $88.8M (modeled range $49.8M–$117.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Momentis Surgical Ltd. at?
Momentis Surgical Ltd.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Tue Jul 15.
What does Momentis Surgical Ltd. do and where is it based?
Momentis Surgical Ltd. operates in the Medical Devices sector, based in Or Yehuda.
Explore related

See where Momentis Surgical Ltd. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Momentis Surgical Ltd., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.